nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR1B—dura mater—bone cancer	0.164	0.211	CbGeAlD
Oxymetazoline—HTR1D—dura mater—bone cancer	0.158	0.204	CbGeAlD
Oxymetazoline—HTR1B—trigeminal nerve—bone cancer	0.0703	0.0906	CbGeAlD
Oxymetazoline—HTR1D—trigeminal nerve—bone cancer	0.0681	0.0878	CbGeAlD
Oxymetazoline—HTR1B—cranial nerve—bone cancer	0.0501	0.0646	CbGeAlD
Oxymetazoline—HTR1D—cranial nerve—bone cancer	0.0485	0.0625	CbGeAlD
Oxymetazoline—HTR2A—trigeminal nerve—bone cancer	0.0338	0.0436	CbGeAlD
Oxymetazoline—HTR2A—cranial nerve—bone cancer	0.0241	0.0311	CbGeAlD
Oxymetazoline—HTR2A—vertebral column—bone cancer	0.0236	0.0305	CbGeAlD
Oxymetazoline—HTR2A—hindlimb—bone cancer	0.0203	0.0262	CbGeAlD
Oxymetazoline—HTR2A—appendage—bone cancer	0.0174	0.0225	CbGeAlD
Oxymetazoline—NISCH—tendon—bone cancer	0.011	0.0142	CbGeAlD
Oxymetazoline—NISCH—bone marrow—bone cancer	0.0107	0.0138	CbGeAlD
Oxymetazoline—NISCH—spinal cord—bone cancer	0.0106	0.0137	CbGeAlD
Oxymetazoline—HTR1D—connective tissue—bone cancer	0.01	0.0129	CbGeAlD
Oxymetazoline—HTR1B—spinal cord—bone cancer	0.00685	0.00884	CbGeAlD
Oxymetazoline—HTR2C—spinal cord—bone cancer	0.00657	0.00847	CbGeAlD
Oxymetazoline—HTR2B—tendon—bone cancer	0.0064	0.00825	CbGeAlD
Oxymetazoline—ADRA2A—connective tissue—bone cancer	0.00585	0.00754	CbGeAlD
Oxymetazoline—ADRA2C—tendon—bone cancer	0.00504	0.00649	CbGeAlD
Oxymetazoline—HTR2A—connective tissue—bone cancer	0.00497	0.00641	CbGeAlD
Oxymetazoline—ADRA2C—spinal cord—bone cancer	0.00486	0.00626	CbGeAlD
Oxymetazoline—ADRA2A—tendon—bone cancer	0.00402	0.00518	CbGeAlD
Oxymetazoline—ADRA2A—spinal cord—bone cancer	0.00388	0.005	CbGeAlD
Oxymetazoline—HTR2A—tendon—bone cancer	0.00342	0.00441	CbGeAlD
Oxymetazoline—HTR2A—spinal cord—bone cancer	0.0033	0.00425	CbGeAlD
Oxymetazoline—ADRA1D—GPCR downstream signaling—IL3—bone cancer	0.000255	0.00114	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—GNA11—bone cancer	0.000254	0.00113	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—SMO—bone cancer	0.000252	0.00112	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—GRM1—bone cancer	0.000251	0.00112	CbGpPWpGaD
Oxymetazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000251	0.00112	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—IL3—bone cancer	0.000249	0.00111	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—GNA11—bone cancer	0.000244	0.00109	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—GRM4—bone cancer	0.000244	0.00109	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RGS1—bone cancer	0.000244	0.00109	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—SMO—bone cancer	0.000242	0.00108	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—ATF1—bone cancer	0.000242	0.00108	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—PLAU—bone cancer	0.000239	0.00106	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—GNA11—bone cancer	0.000237	0.00106	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL3—bone cancer	0.000236	0.00105	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—SMO—bone cancer	0.000235	0.00105	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—GRM1—bone cancer	0.000234	0.00104	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RGS1—bone cancer	0.000234	0.00104	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—GRM4—bone cancer	0.000234	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	0.000233	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—SMO—bone cancer	0.000232	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL3—bone cancer	0.000231	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—GNA11—bone cancer	0.00023	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—IL3—bone cancer	0.00023	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RGS1—bone cancer	0.000228	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—GRM4—bone cancer	0.000228	0.00101	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—GRM4—bone cancer	0.000224	0.000998	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RGS1—bone cancer	0.000224	0.000998	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—PLAU—bone cancer	0.000223	0.000994	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—GNA11—bone cancer	0.000221	0.000986	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—IL3—bone cancer	0.000221	0.000984	CbGpPWpGaD
Oxymetazoline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000218	0.00097	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—GNA11—bone cancer	0.000215	0.000959	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—IL3—bone cancer	0.000215	0.000957	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—GNA11—bone cancer	0.000212	0.000944	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—GNA11—bone cancer	0.000212	0.000943	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—IL3—bone cancer	0.000211	0.000942	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—GRM1—bone cancer	0.000211	0.000941	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—SMO—bone cancer	0.00021	0.000936	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL3—bone cancer	0.000209	0.000931	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000208	0.000929	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	0.000207	0.000923	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—SMO—bone cancer	0.000206	0.000917	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RGS1—bone cancer	0.000203	0.000905	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—GRM4—bone cancer	0.000203	0.000905	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—GRM1—bone cancer	0.000203	0.000904	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TGFBR2—bone cancer	0.000201	0.000898	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL3—bone cancer	0.000201	0.000894	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—GRM4—bone cancer	0.000199	0.000886	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RGS1—bone cancer	0.000199	0.000886	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—GRM1—bone cancer	0.000197	0.000879	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL3—bone cancer	0.000195	0.000869	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—GRM1—bone cancer	0.000194	0.000865	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SMO—bone cancer	0.000193	0.000858	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	0.000192	0.000858	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—GNA11—bone cancer	0.000192	0.000856	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL3—bone cancer	0.000192	0.000856	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—IL3—bone cancer	0.000192	0.000855	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—SMO—bone cancer	0.000191	0.000852	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IGF1R—bone cancer	0.00019	0.000845	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000189	0.000843	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SMO—bone cancer	0.000189	0.00084	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—GNA11—bone cancer	0.000188	0.000838	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—IL3—bone cancer	0.000188	0.000837	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000185	0.000825	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RGS1—bone cancer	0.000185	0.000824	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—GRM4—bone cancer	0.000185	0.000824	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—PLAU—bone cancer	0.000181	0.000807	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SMO—bone cancer	0.000177	0.000789	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—GNA11—bone cancer	0.000176	0.000785	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—GRM1—bone cancer	0.000176	0.000785	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ENO2—bone cancer	0.000175	0.000781	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—GNA11—bone cancer	0.000175	0.000779	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—IL3—bone cancer	0.000174	0.000778	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL3—bone cancer	0.000174	0.000776	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—GRM1—bone cancer	0.000172	0.000769	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—GNA11—bone cancer	0.000172	0.000769	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL3—bone cancer	0.000171	0.00076	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SMO—bone cancer	0.000165	0.000735	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—ATF1—bone cancer	0.000164	0.00073	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—DHFR—bone cancer	0.000163	0.000725	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—GNA11—bone cancer	0.000162	0.000722	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—ATF1—bone cancer	0.00016	0.000715	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—GRM1—bone cancer	0.00016	0.000714	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL3—bone cancer	0.00016	0.000712	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL3—bone cancer	0.000158	0.000706	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL3—bone cancer	0.000156	0.000697	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—GNA11—bone cancer	0.000152	0.000678	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—GNA11—bone cancer	0.000151	0.000672	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—ATF1—bone cancer	0.000151	0.000671	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SMO—bone cancer	0.000149	0.000663	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL3—bone cancer	0.000147	0.000655	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SMO—bone cancer	0.000143	0.000637	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ENO2—bone cancer	0.000142	0.000635	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—ATF1—bone cancer	0.00014	0.000625	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SMO—bone cancer	0.000139	0.000619	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—CYP3A4—bone cancer	0.000138	0.000614	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—KIT—bone cancer	0.000137	0.000613	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SMO—bone cancer	0.000137	0.00061	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL3—bone cancer	0.000137	0.000609	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TGFBR2—bone cancer	0.000137	0.000609	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—GNA11—bone cancer	0.000136	0.000607	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TGFBR2—bone cancer	0.000134	0.000596	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—DHFR—bone cancer	0.000132	0.000589	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—GNA11—bone cancer	0.000131	0.000582	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—BRAF—bone cancer	0.000129	0.000576	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IGF1R—bone cancer	0.000128	0.000573	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—GNA11—bone cancer	0.000127	0.000567	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—ATF1—bone cancer	0.000127	0.000564	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IGF1R—bone cancer	0.000126	0.000561	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TGFBR2—bone cancer	0.000126	0.00056	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—EGFR—bone cancer	0.000125	0.000558	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—GNA11—bone cancer	0.000125	0.000558	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SMO—bone cancer	0.000124	0.000553	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—GNA11—bone cancer	0.000123	0.00055	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL3—bone cancer	0.000123	0.00055	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SMO—bone cancer	0.000122	0.000542	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000122	0.000542	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL3—bone cancer	0.000118	0.000528	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—ATF1—bone cancer	0.000118	0.000527	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IGF1R—bone cancer	0.000118	0.000527	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—GSTP1—bone cancer	0.000118	0.000525	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	0.000117	0.000521	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—ATF1—bone cancer	0.000116	0.000518	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL3—bone cancer	0.000115	0.000514	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000113	0.000506	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL3—bone cancer	0.000113	0.000506	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SMO—bone cancer	0.000113	0.000503	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—CYP3A4—bone cancer	0.000112	0.000499	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—GNA11—bone cancer	0.000111	0.000495	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IGF1R—bone cancer	0.00011	0.00049	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—MDM2—bone cancer	0.000108	0.000482	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	0.000106	0.00047	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—ATF1—bone cancer	0.000106	0.00047	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—ATF1—bone cancer	0.000103	0.00046	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—GNA11—bone cancer	0.000103	0.00046	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL3—bone cancer	0.000103	0.000459	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TGFBR2—bone cancer	0.000101	0.000452	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL3—bone cancer	0.000101	0.000449	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IGF1R—bone cancer	9.93e-05	0.000442	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	9.86e-05	0.000439	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	9.7e-05	0.000432	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—ATF1—bone cancer	9.6e-05	0.000428	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—TP53—bone cancer	9.6e-05	0.000428	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—GSTP1—bone cancer	9.57e-05	0.000427	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IGF1R—bone cancer	9.53e-05	0.000425	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—JUN—bone cancer	9.41e-05	0.000419	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL3—bone cancer	9.36e-05	0.000417	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—KIT—bone cancer	9.32e-05	0.000415	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IGF1R—bone cancer	9.27e-05	0.000413	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—MMP9—bone cancer	9.15e-05	0.000408	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IGF1R—bone cancer	9.13e-05	0.000407	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—KIT—bone cancer	9.12e-05	0.000407	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—TP53—bone cancer	8.96e-05	0.0004	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TGFBR2—bone cancer	8.8e-05	0.000392	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—BRAF—bone cancer	8.76e-05	0.00039	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	8.62e-05	0.000384	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—BRAF—bone cancer	8.58e-05	0.000382	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—KIT—bone cancer	8.57e-05	0.000382	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—EGFR—bone cancer	8.49e-05	0.000378	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—EGFR—bone cancer	8.31e-05	0.00037	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IGF1R—bone cancer	8.28e-05	0.000369	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IGF1R—bone cancer	8.11e-05	0.000361	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—BRAF—bone cancer	8.06e-05	0.000359	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	8.01e-05	0.000357	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—KIT—bone cancer	7.98e-05	0.000355	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—EGFR—bone cancer	7.81e-05	0.000348	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IGF1R—bone cancer	7.53e-05	0.000336	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—BRAF—bone cancer	7.5e-05	0.000334	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—EGFR—bone cancer	7.4e-05	0.00033	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MDM2—bone cancer	7.34e-05	0.000327	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—TP53—bone cancer	7.28e-05	0.000325	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—EGFR—bone cancer	7.27e-05	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—KIT—bone cancer	7.2e-05	0.000321	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MDM2—bone cancer	7.19e-05	0.00032	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—KIT—bone cancer	6.91e-05	0.000308	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—BRAF—bone cancer	6.77e-05	0.000302	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MDM2—bone cancer	6.75e-05	0.000301	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—KIT—bone cancer	6.73e-05	0.0003	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—KIT—bone cancer	6.62e-05	0.000295	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—EGFR—bone cancer	6.56e-05	0.000292	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—BRAF—bone cancer	6.5e-05	0.00029	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—JUN—bone cancer	6.38e-05	0.000284	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—BRAF—bone cancer	6.32e-05	0.000282	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—EGFR—bone cancer	6.3e-05	0.000281	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MDM2—bone cancer	6.28e-05	0.00028	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—JUN—bone cancer	6.25e-05	0.000278	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—BRAF—bone cancer	6.22e-05	0.000277	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TP53—bone cancer	6.21e-05	0.000277	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MMP9—bone cancer	6.21e-05	0.000277	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—EGFR—bone cancer	6.13e-05	0.000273	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTGS2—bone cancer	6.11e-05	0.000272	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MMP9—bone cancer	6.08e-05	0.000271	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—EGFR—bone cancer	6.03e-05	0.000269	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—KIT—bone cancer	6e-05	0.000268	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—KIT—bone cancer	5.88e-05	0.000262	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—JUN—bone cancer	5.87e-05	0.000261	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MMP9—bone cancer	5.71e-05	0.000254	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MDM2—bone cancer	5.67e-05	0.000253	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—BRAF—bone cancer	5.64e-05	0.000252	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—BRAF—bone cancer	5.53e-05	0.000246	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—bone cancer	5.47e-05	0.000244	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—KIT—bone cancer	5.46e-05	0.000243	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—JUN—bone cancer	5.46e-05	0.000243	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MDM2—bone cancer	5.45e-05	0.000243	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—bone cancer	5.36e-05	0.000239	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MMP9—bone cancer	5.31e-05	0.000237	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MDM2—bone cancer	5.3e-05	0.000236	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MDM2—bone cancer	5.21e-05	0.000232	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—BRAF—bone cancer	5.13e-05	0.000229	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—bone cancer	5.02e-05	0.000224	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—bone cancer	4.98e-05	0.000222	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—bone cancer	4.96e-05	0.000221	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—JUN—bone cancer	4.93e-05	0.00022	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—bone cancer	4.91e-05	0.000219	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MMP9—bone cancer	4.8e-05	0.000214	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—JUN—bone cancer	4.73e-05	0.000211	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MDM2—bone cancer	4.73e-05	0.000211	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MDM2—bone cancer	4.63e-05	0.000206	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—bone cancer	4.61e-05	0.000206	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MMP9—bone cancer	4.61e-05	0.000205	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—JUN—bone cancer	4.6e-05	0.000205	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—JUN—bone cancer	4.53e-05	0.000202	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MMP9—bone cancer	4.48e-05	0.0002	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MMP9—bone cancer	4.41e-05	0.000196	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MDM2—bone cancer	4.3e-05	0.000192	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—bone cancer	4.29e-05	0.000191	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—bone cancer	4.21e-05	0.000188	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—bone cancer	4.12e-05	0.000184	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—JUN—bone cancer	4.11e-05	0.000183	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—JUN—bone cancer	4.02e-05	0.000179	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MMP9—bone cancer	4e-05	0.000178	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MMP9—bone cancer	3.92e-05	0.000175	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—bone cancer	3.88e-05	0.000173	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—bone cancer	3.87e-05	0.000173	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—JUN—bone cancer	3.74e-05	0.000167	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—bone cancer	3.72e-05	0.000166	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MMP9—bone cancer	3.64e-05	0.000162	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—bone cancer	3.62e-05	0.000161	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—bone cancer	3.6e-05	0.000161	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—bone cancer	3.56e-05	0.000159	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—bone cancer	3.25e-05	0.000145	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—bone cancer	3.23e-05	0.000144	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—bone cancer	3.16e-05	0.000141	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—bone cancer	3.12e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—bone cancer	3.04e-05	0.000135	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—bone cancer	2.99e-05	0.000133	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—bone cancer	2.94e-05	0.000131	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—bone cancer	2.71e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—bone cancer	2.66e-05	0.000118	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—bone cancer	2.47e-05	0.00011	CbGpPWpGaD
